KR0185717B1 - 글리시레틴산 유도체 - Google Patents

글리시레틴산 유도체 Download PDF

Info

Publication number
KR0185717B1
KR0185717B1 KR1019920004158A KR920004158A KR0185717B1 KR 0185717 B1 KR0185717 B1 KR 0185717B1 KR 1019920004158 A KR1019920004158 A KR 1019920004158A KR 920004158 A KR920004158 A KR 920004158A KR 0185717 B1 KR0185717 B1 KR 0185717B1
Authority
KR
South Korea
Prior art keywords
compound
phosphoryl
ascorbyl
composition
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019920004158A
Other languages
English (en)
Korean (ko)
Other versions
KR920018062A (ko
Inventor
가즈미 오가따
교오조 야마모또
레이꼬 마쓰다
Original Assignee
요시다 쇼우지
센쥬세이야꾸가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시다 쇼우지, 센쥬세이야꾸가부시끼가이샤 filed Critical 요시다 쇼우지
Publication of KR920018062A publication Critical patent/KR920018062A/ko
Application granted granted Critical
Publication of KR0185717B1 publication Critical patent/KR0185717B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019920004158A 1991-03-13 1992-03-13 글리시레틴산 유도체 Expired - Fee Related KR0185717B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP91-128799 1991-03-13
JP3128799A JP2998287B2 (ja) 1991-03-13 1991-03-13 グリチルレチン酸誘導体

Publications (2)

Publication Number Publication Date
KR920018062A KR920018062A (ko) 1992-10-21
KR0185717B1 true KR0185717B1 (ko) 1999-05-15

Family

ID=14993725

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920004158A Expired - Fee Related KR0185717B1 (ko) 1991-03-13 1992-03-13 글리시레틴산 유도체

Country Status (10)

Country Link
US (1) US5229378A (enExample)
EP (1) EP0503582B1 (enExample)
JP (1) JP2998287B2 (enExample)
KR (1) KR0185717B1 (enExample)
AT (1) ATE161848T1 (enExample)
CA (1) CA2062652A1 (enExample)
DE (1) DE69223827T2 (enExample)
ES (1) ES2112870T3 (enExample)
RU (1) RU2065864C1 (enExample)
TW (1) TW201750B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254321B (it) * 1992-04-10 1995-09-14 Kemiprogress S R L Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
US5519008A (en) * 1992-09-10 1996-05-21 Glycomed Incorporated Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules ELAM-1 (E-selectin) and LECAM-1 (L-selectin)
US5527890A (en) * 1993-04-16 1996-06-18 Glycomed Incorporated Derivatives of triterpenoid acids and uses thereof
CN1034334C (zh) * 1993-08-14 1997-03-26 贵州省中医研究所 齐酞酸钠及其药物组合物
US5866147A (en) * 1995-05-15 1999-02-02 Avon Products, Inc. Ascorbyl-phosphoryl-cholesterol
US5922335A (en) * 1995-05-15 1999-07-13 Avon Products, Inc. Uses for ascorbyl-phosphoryl-cholesterol in topical compositions
US5951990A (en) * 1995-05-15 1999-09-14 Avon Products, Inc. Ascorbyl-phosphoryl-cholesterol
US6162450A (en) * 1995-05-15 2000-12-19 Avon Products, Inc. Uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same
US5607968A (en) * 1995-06-07 1997-03-04 Avon Products, Inc. Topical alkyl-2-O-L-ascorbyl-phosphates
DE69605556T2 (de) * 1996-05-14 2000-06-15 Avon Products, Inc. Ascorbyl-phosphorylcholesterol
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
AU2002233643B2 (en) * 2001-02-16 2007-07-26 Asubio Pharma Co., Ltd. Methods of treating diseases in association with decrease in the expression of AOP-1 gene or AOP-1 and remedies for the diseases
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
WO2005026209A2 (en) * 2003-09-11 2005-03-24 Critical Therapeutics, Inc. Monoclonal antibodies against hmgb1
EP1909834A2 (en) * 2005-07-18 2008-04-16 Critical Therapeutics, Inc. Use of hmgb1 antagonists for the treatment of inflammatory skin conditions
WO2007076200A2 (en) * 2005-11-28 2007-07-05 Medimmune, Inc. Antagonists of hmgb1 and/or rage and methods of use thereof
RU2623876C2 (ru) * 2014-11-10 2017-06-29 Александр Владимирович Диковский Фармацевтическая композиция для лечения гиперлипидемии
RU2611362C1 (ru) * 2015-11-26 2017-02-21 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Водорастворимая композиция, обладающая противоопухолевой активностью и способ ее получения
CN115813859B (zh) * 2022-12-13 2024-05-17 五邑大学 一种甘草次酸配体脂质体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL24113A (en) * 1965-08-08 1969-06-25 Greidinger D Glycyrrhetic acid phosphoric acid ester and salts thereof
GB1093908A (en) * 1965-11-26 1967-12-06 Biorex Laboratories Ltd New derivatives of glycyrrhetinic acid
GB1229562A (enExample) * 1969-01-17 1971-04-28
US3734944A (en) * 1970-05-15 1973-05-22 Biorex Laboratories Ltd Glycyrrhetinic acid esters
GB1476053A (en) * 1975-02-07 1977-06-10 Biorex Laboratories Ltd Glycyrrhetinic acid derivatives
US4939128A (en) * 1988-04-25 1990-07-03 Takeda Chemical Industries, Ltd. Ester of ascorbic acid 2-phosphate and pharmaceutical use

Also Published As

Publication number Publication date
CA2062652A1 (en) 1992-09-14
JPH04330088A (ja) 1992-11-18
ES2112870T3 (es) 1998-04-16
DE69223827T2 (de) 1998-06-18
RU2065864C1 (ru) 1996-08-27
ATE161848T1 (de) 1998-01-15
EP0503582B1 (en) 1998-01-07
TW201750B (enExample) 1993-03-11
KR920018062A (ko) 1992-10-21
JP2998287B2 (ja) 2000-01-11
DE69223827D1 (de) 1998-02-12
US5229378A (en) 1993-07-20
EP0503582A1 (en) 1992-09-16

Similar Documents

Publication Publication Date Title
KR0185717B1 (ko) 글리시레틴산 유도체
US4939128A (en) Ester of ascorbic acid 2-phosphate and pharmaceutical use
RU2049771C1 (ru) Хиноновые производные и их фармакологически приемлемые соли
Sheng et al. Novel hybrids of 3-n-butylphthalide and edaravone: Design, synthesis and evaluations as potential anti-ischemic stroke agents
US5583239A (en) Antimicrobial sterol conjugates
CN103342729B (zh) 咖啡酰基取代的五环三萜类衍生物及其用途
EP0019081A1 (de) Neue Flavonderivate, deren Herstellung, diese neuen und bekannte Flavone als antivirale Wirkstoffe und sie enthaltende pharmazeutische Präparate
CN115477681A (zh) 一种五环三萜皂苷衍生物及制备方法与应用
WO1996000236A1 (en) Triterpene derivative and medicinal composition
JP5680535B2 (ja) 新規フラバノン誘導体
EP0125195A1 (fr) Nouveaux acides flavonecarboxyliques-4', leur méthode de préparation et leur application thérapeutique
WO2018086242A1 (zh) pH敏感的轴向取代硅酞菁配合物及其制备方法和在医药上的应用
US4539326A (en) 5-Oxo-5H-(1)benzopyrano(2,3-b)pyridine derivatives, their production and use as anti-inflammatory agents
CA2178479C (en) Chroman derivatives
DK154650B (da) Analogifremgangsmaade til fremstilling af sukkerderivater
US5698585A (en) Pharmaceutical preparation for prevention and/or treatment for cataract
JP2018184414A (ja) 新規フラボノイド化合物およびその使用
JP2013539779A (ja) 化合物
DE69016914T2 (de) Phospholipidderivate.
JP2011525912A (ja) 水に対する溶解度が改善された新規のシンナムアルデヒド誘導体、その製造方法、それを含む抗癌剤組成物およびそれを用いた癌治療方法
JPH0377179B2 (enExample)
EP1668021A2 (fr) Nouveaux composes du thioxylose, procede de preparation, compositions pharmaceutiques les contenant et leur utilisation en therapeutique
WO2001018028A1 (de) Neue c-13-substituierte estra-1,3,5(10)-trien-3-yl-sulfamate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen zur hemmung von östron sulfatase
Sorokina et al. Antitumor Activity of Amides of Dihydrobetulonic Acid in vitro and in vivo
CN120289552A (zh) 一种甾体磷酸酯化合物及其应用

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20011229

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20011229

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000